NVO - Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines | Benzinga
Drugmaker Eli Lilly And Co (NYSE:LLY) announced on Thursday a new website that allows patients to get a weight loss drug prescription through a telehealth provider.
LillyDirect offers disease management resources, including access to independent healthcare providers, tailored support and direct home delivery of select Lilly medicines through third-party pharmacy dispensing services.
In November, the FDA approved the company’s Zepbound (tirzepatide) for obesity treatment.
Also Read: Obesity/Diabetes Drug Class GLP-1s’ Cost-Saving Potential: ...